Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

cementum attachment protein Inhibitors

Cementum attachment protein inhibitors belong to a distinctive chemical class that primarily focuses on modulating certain biological processes related to cementum attachment. Cementum attachment refers to the natural adhesion of specialized connective tissues, such as cementum, to the tooth root, facilitating the stability and support of teeth within the oral cavity. The inhibitors within this chemical class are designed to interact with specific molecular targets involved in cementum attachment, thereby influencing the intricate cellular mechanisms that regulate the attachment process.

These inhibitors are meticulously developed through research-driven approaches to ensure their effectiveness in altering the biochemical pathways associated with cementum attachment. By targeting the key molecular players in this process, cementum attachment protein inhibitors offer a novel approach to influencing the dynamics of tooth support and stability. Their mode of action involves intricate interactions at the molecular level, aiming to decipher the complexities of cementum attachment and unveil new avenues for biological intervention.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Alendronate acid

66376-36-1sc-337520
5 g
$135.00
2
(0)

Alendronate, a bisphosphonate, functions similarly to etidronate by inhibiting osteoclast activity, thereby impacting cementum attachment through its effects on bone remodeling.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$92.00
$256.00
5
(0)

Zoledronic acid, another bisphosphonate, inhibits osteoclasts and bone resorption. Its mechanism of action is similar to other bisphosphonates and indirectly affects cementum attachment.

Odanacatib

603139-19-1sc-364675
sc-364675A
sc-364675B
5 mg
25 mg
250 mg
$218.00
$993.00
$1982.00
2
(1)

Odanacatib is a selective cathepsin K inhibitor that reduces bone resorption by targeting osteoclast activity. By modulating bone remodeling, it could potentially influence cementum attachment.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine, a lysosomotropic agent, can affect osteoclast function and bone resorption, which might indirectly impact cementum attachment.